Income Statement
AGILON HEALTH, INC.
AGL
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
5,932.58 | 6,060.53 | 4,316.36 | 2,708.21 | 1,833.56 |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
5,932.58 | 6,060.53 | 4,316.36 | 2,708.21 | 1,833.56 |
|
Operating Expenses
|
238.54 | 268.91 | 285.76 | 2,828.64 | 2,227.51 |
|
Research & Development
|
- | - | - | - | - |
|
Selling, General & Administrative
|
238.54 | 268.91 | 285.76 | 218.95 | 455.82 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
5,694.04 | 5,791.62 | 4,030.60 | -120.43 | -393.95 |
|
Non-Operating Income
|
67.62 | 34.49 | 27.84 | 24.73 | -4.50 |
|
Interest Income
|
0.46 | 0.60 | 0.64 | 0.73 | 0.45 |
|
Interest Expense
|
- | - | 6.66 | 4.53 | 6.15 |
|
Other Non-Op Income / Expense
|
-1.84 | 14.99 | 16.49 | 10.72 | -6.77 |
|
Income Before Tax
|
-404.10 | -248.83 | -194.46 | -105.69 | -404.60 |
|
Income Tax Expense
|
-12.75 | 11.33 | 68.13 | 0.86 | 1.89 |
|
Non-Controlling Interest
|
0.00 | 0.05 | -0.21 | -0.31 | -0.30 |
|
Net Income
|
-391.35 | -260.15 | -262.60 | -106.55 | -406.49 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
5,722.63 | 5,816.08 | 4,046.65 | -106.66 | -379.41 |
|
Earnings Per Share (Basic)
|
- | - | - | - | - |
|
Diluted EPS
|
- | - | - | - | - |
|
Weighted Average Shares
|
413.97 | 410.97 | 408.92 | 408.15 | - |
|
Diluted Weighted Avg Shares
|
413.97 | 410.97 | 408.92 | 408.15 | - |
|
Comprehensive Income
|
-390.34 | -257.94 | -259.33 | -112.11 | - |